The cost of doing business was expected to be $35m higher.
Traders will now be watching to see if the non-farm payrolls employment data release puts even more pressure on the policymakers to hike interest rates.
Both the tablet and intravenous forms of Maxigesic could be approved, signalling the start of its entry into the big US market.
New Zealand-based tech translation company Straker Translations is to buy Belgium firm IDEST.